Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Biomarker Discovery & Validation
FDA clears another blood-based TBI POC test
By
LabPulse.com staff writers
Abbott furthers its point-of-care (POC) assay for measuring traumatic brain injury biomarkers from whole blood.
April 1, 2024
Researchers map protein biomarkers in sepsis fight
By
Liz Carey
Swedish researchers are mapping patterns of protein biomarkers in sepsis that could be useful for simple blood tests in the emergency department, according to research to be presented at ECCMID 2024.
April 2, 2024
Two new directions in Parkinson’s testing
By
Liz Carey
Two recent Parkinson’s announcements suggest a new biomarker test panel coming, as well as cell culture systems for studying Parkinson’s in the laboratory.
December 11, 2023
Study: Blood test improves bipolar disorder diagnosis through biomarkers
By
Matt Limb
Diagnosis of bipolar disorder could be improved using a simple blood test to identify biomarkers associated with the condition, say researchers.
November 2, 2023
Researchers develop nanopore sequencing method for mapping disease biomarkers
By
Matt Limb
A nanopore sequencing method that can map dozens of biomarkers at the same time has the potential to transform testing for heart disease and other conditions, say researchers.
October 11, 2023
Quest Diagnostics teams up with Envision Science on prostate cancer biomarkers
By
Matt Limb
The test aims to improve the accuracy of grading biopsies for prostate cancer, which is one of the most prevalent and deadly cancers affecting men.
July 27, 2023
Physicians advocate for ‘careful’ use of osteoporosis bone turnover marker testing
By
Nick Paul Taylor
Knowing the rate of bone matrix removal or deposition can help physicians understand if a patient is at risk of fractures or is responding to treatment.
July 24, 2023
Quest launches biomarker test to improve grading of prostate cancer biopsies
By
Nick Paul Taylor
Building on the Australian research and working with Envision Sciences, the Australian diagnostics company that owns the biomarker intellectual property, Quest’s subspecialty pathology business, AmeriPath, has developed a tissue-based test.
July 17, 2023
DiamiR Biosciences partners with JADBio on diagnostic tests, validation for biomarker panels
By
Matt Limb
Under the deal, DiamiR will apply the capabilities of JADBio’s Automated Machine Learning (AutoML) bioinformatics platform and services to its own microRNA platform.
July 12, 2023
Intus Bio buys Pattern Genomics to enhance microbiome analysis capabilities
By
Nick Paul Taylor
Intus Bio sees the integration enhancing the platform with machine-learning tools for biomarker discovery and patient stratification, supporting the firm’s work in turning microbiome technologies into practical medical and pharmaceutical applications.
June 29, 2023
Nucleai, Mayo Clinic partner on digital pathology
By
LabPulse.com staff writers
The collaboration combines Nucleai’s AI-enabled spatial biology technology with Mayo’s longitudinally annotated, multimodal data sets, lab services, and clinical diagnostic footprint.
June 5, 2023
Blood biomarker in study predicts whether the cognitively healthy will develop Alzheimer’s
By
LabPulse.com staff writers
Astrocytes -- a subtype of glial cells that make up most cells in the human central nervous system -- may be the key driver of Alzheimer's disease progression, researchers said.
May 30, 2023
Page 1 of 4
Next Page